NCT01489930

Brief Summary

Loss of skeletal muscle strength and skeletal muscle mass occurs with of aging. This are-related decline in skeletal muscle mass and skeletal muscle strength is a major underlying factor contributing to many of the metabolic disorders and frailty of the investigators rapidly expanding aging population. Endurance (aerobic) and resistance exercise training programs have been shown to effectively reverse the age-related decline in metabolic and contractile muscle functions. The investigators will measure synthesis rates of individual muscle proteins in 36 each of young (18-30 yrs) and 36 older (\> 65 yrs) people to determine their response to 8 weeks each of endurance, resistance, combined endurance and resistance training, or placebo exercise training. Hypotheses.

  1. 1.to measure fractional synthesis rates of multiple muscle proteins and identify those that are enhanced by an endurance exercise program
  2. 2.to determine whether changes in protein synthesis in response to endurance exercise programs are dependent on age
  3. 3.to measure fractional muscle synthesis rates of multiple muscle proteins and to identify those that are enhanced by a resistance exercise program
  4. 4.to determine whether changes in protein synthesis in response to resistance exercise programs are dependent on age

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2011

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2011

Completed
24 days until next milestone

First Posted

Study publicly available on registry

December 12, 2011

Completed
Last Updated

December 12, 2011

Status Verified

December 1, 2011

Enrollment Period

2.8 years

First QC Date

November 18, 2011

Last Update Submit

December 9, 2011

Conditions

Keywords

ExerciseAgingSarcopeniaMitochondria

Outcome Measures

Primary Outcomes (1)

  • Skeletal Muscle Protein Synthesis

    The investigators will determine the change from baseline in skeletal muscle protein synthesis. Measurments will be performed at baseline and following 8 weeks of exercise training.

    Measured at week 0 (baseline) and week 8

Secondary Outcomes (1)

  • Mitochondrial Function

    Measured at week 0 (baseline) and week 8

Study Arms (3)

Endurance Exercise

EXPERIMENTAL

Participants will perform 8-weeks of moderate intensity endurance (cycling) exercise

Behavioral: Endurance exercise

Resistance Exercise

EXPERIMENTAL

Participants will perform 8-weeks of whole-body resistance exercise training.

Behavioral: Resistance exercise

Control / Combined Training

EXPERIMENTAL

Participants will perform 8-weeks of no exercise, followed by an additional 8-weeks of combined endurance plus resistance exercise training.

Behavioral: Control/Combined training

Interventions

Participants will perform 8-weeks of endurance exercise training. Participants will train 5 days per week for 60 min at 65% of VO2 peak.

Endurance Exercise

Participants will perform 8-weeks of resistance exercise training. Participants will train 4 days per week for \~60 min. Two days will focus on lower body resistance training and two days will focus on upper body.

Resistance Exercise

Participants will perform 8-weeks of no exercise (control), followed by 8-weeks of combined endurance and resistance training. Participants will endurance train 5 days per week for 30 min at 65% of VO2 peak and resistance train 4 days per week for 30 min.

Control / Combined Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy
  • to 30 or \>65 years
  • Males and Females

You may not qualify if:

  • Regular Exercise Program
  • Smoking
  • Cardiometabolic Disease (diabetes, cardiovascular disease, thyroid disorders)
  • Drugs known to impair metabolic function (beta blockers, steroids)
  • Allergies to lidocaine
  • Physical disability that precludes exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Related Publications (1)

  • Irving BA, Lanza IR, Henderson GC, Rao RR, Spiegelman BM, Nair KS. Combined training enhances skeletal muscle mitochondrial oxidative capacity independent of age. J Clin Endocrinol Metab. 2015 Apr;100(4):1654-63. doi: 10.1210/jc.2014-3081. Epub 2015 Jan 19.

MeSH Terms

Conditions

SarcopeniaMotor Activity

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • K. Sreekumaran Nair, MD, PD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

November 18, 2011

First Posted

December 12, 2011

Study Start

May 1, 2008

Primary Completion

February 1, 2011

Study Completion

February 1, 2011

Last Updated

December 12, 2011

Record last verified: 2011-12

Locations